Collaboration will support Sanofi’s use of CytoReason’s computational disease models to develop new targets for inflammatory bowel disease (IBD).

Read more here.

• SEO Powered Content & PR Distribution. Get Amplified Today.
• Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
• Source: https://blog.ourcrowd.com/cytoreason-to-license-its-ibd-disease-model-to-sanofi-in-expanded-multiyear-multimillion-dollar-deal/